About Joseph

Joseph D. Tucker, MD, PhD, AM is an infectious diseases physician with a special interest in using crowdsourcing to improve health. He is Assistant Professor of Medicine and Director of UNC Project-China. He leads US National Institutes of Health grants totaling over seven million USD. His team’s ongoing research investigates crowdsourcing to promote HIV testing, the social science and ethics of curing HIV, the health of African migrants in Guangzhou, and trust in patient-physician relationships. His New England Journal of Medicine article on the social roots of syphilis in China helped catalyze policy change and spurred the development of a national 10 year plan to control syphilis. He is the Chairman of the Steering Committee of Social Entrepreneurship for Sexual Health (SESH), a group focused on using crowdsourcing to improve health. He helped to organize the HepTestContest soliciting innovative HBV and HCV testing models. He is a Term Member of the Council on Foreign Relations. He has contributed to several World Health Organization guidelines. Joe received his BA from Swarthmore, MD from UNC, AM (RSEA) from Harvard, and PhD from the London School of Hygiene and Tropical Medicine.

This speaker will be presenting at the following session(s)

  • Strategic direction 5: Innovation for acceleration


    Day: Friday 3

    Time: 14:00

    Innovation can help drive towards the overall objective of hepatitis elimination in a wide range of settings. This innovation session will highlight innovations related to hepatitis B and C products, programs and policies.


    • Introduction and importance of innovation.
    • Innovation plenary.
    • Product innovation.
      Dr Francesco Marinucci, Foundation for Innovative New Diagnostics
    • Program innovation.
      Dr Joseph Tucker, University of North Carolina
    • Policy innovation.
      Dr Bobby John, Global Health Advocates
    • Wrap-up panel.

    Session objectives:

    • Learn the importance of innovation in developing hepatitis B and C control programs, policies and products.
    • Understand new products for hepatitis B and C control that could accelerate detection, treatment and retention.
    • Discuss new policies for expanding access to hepatitis B and C testing, treatment and prevention strategies.
    • Learn about new programs and public health interventions to optimize comprehensive hepatitis care.